Evidence map›Paper›PMID 40112257›Full record

ArticleJCO global oncology2025

Peer Navigation for HIV-Associated Kaposi Sarcoma in Kenya: The Power of the Survivor's Voice.

Fredrick Shiravika, Alexis G Strahan, Morvarid Zehtab, Linda Chemtai, Celestine Lagat, Emily Mulanda, Sigrid M Collier, Elyne Rotich, Toby Maurer, Jeff Martin and 5 more

Abstract read
In one paragraph

Article in JCO global oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fredrick ShiravikaAcademic Model Providing Access to Healthcare, Moi Teaching & Referral Hospital, Eldoret, Kenya.
Alexis G StrahanMassachusetts General Hospital, Boston, MA.
Morvarid ZehtabMassachusetts General Hospital, Boston, MA.ORCID 0009-0009-8129-3872
Linda ChemtaiAcademic Model Providing Access to Healthcare, Moi Teaching & Referral Hospital, Eldoret, Kenya.
Celestine LagatAcademic Model Providing Access to Healthcare, Moi Teaching & Referral Hospital, Eldoret, Kenya.
Emily MulandaAcademic Model Providing Access to Healthcare, Moi Teaching & Referral Hospital, Eldoret, Kenya.
Sigrid M CollierDepartment of Dermatology, University of Washington, Seattle, WA.ORCID 0000-0002-4143-0408
Elyne RotichAcademic Model Providing Access to Healthcare, Moi Teaching & Referral Hospital, Eldoret, Kenya.
Toby MaurerDepartment of Dermatology, Indiana University, Indianapolis, IN.
Jeff MartinDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-9773-3256
Jesse OpakasMoi Teaching and Referral Hospital, Eldoret, Kenya.ORCID 0009-0007-5464-533X
Helen ByakwagaInfectious Disease Institute, Makerere University, Kampala, Uganda.
Aggrey SemeereInfectious Disease Institute, Makerere University, Kampala, Uganda.ORCID 0000-0003-1826-2239
Samson KipronoAcademic Model Providing Access to Healthcare, Moi Teaching & Referral Hospital, Eldoret, Kenya.ORCID 0000-0001-5010-1369
Esther E FreemanDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-7751-9466

Funding

NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related CancersU54CA254571 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARTIN, JEFFREY N · 2020 to 2025
$5.6M
Improving the Care Cascade for HIV-associated Kaposi's Sarcoma in sub-Saharan AfricaK23AI136579 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI FREEMAN, ESTHER E · 2018 to 2022
$1.1M
FIC NIH HHS D43 TW009345NCI NIH HHS U54 CA254571NIAID NIH HHS K23 AI136579
6 · The paper itself

Abstract

purposeSub-Saharan Africa bears a disproportionate share of the global burden of HIV- associated Kaposi's sarcoma (KS), with high morbidity and mortality rates influenced by stigma, delayed diagnosis, and limited access to care. This study examines Peer Navigation, through both personal and clinical perspectives, as a potential intervention to improve outcomes for those living with KS in western Kenya. PATIENTS AND

methodsThis study centers on the lived experience of one KS survivor who became a Peer Navigator in western Kenya. The narrative captures his journey from diagnosis to treatment and the subsequent impact of guiding others through their healthcare journey as a Peer Navigator.

resultsBetween October 2021 and July 2024, the Peer Navigator provided support to 77 patients. These interactions led to improvements in patient knowledge, reduced feelings of social isolation, renewed hope for recovery, and increased confidence in treatment options.

conclusionPeer Navigation plays a crucial role in improving outcomes for patients living with HIV- associated KS. By integrating the survivor's voice, this model of care delivery provides invaluable emotional and social support, fostering improved patient-reported outcomes and encouraging treatment adherence, thereby offering a transformative model for care delivery.

Indexed as

Cancer SurvivorsHIV InfectionsPeer GroupSarcoma, KaposiAdultFemaleHumansKenyaMaleMiddle AgedPatient NavigationSocial StigmaSocial Support

Identifiers

PMID40112257
PMCPMC12004984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.